This test helps screen for liver cancer by measuring AFP and PIVKA-II. It can improve early detection and assess individual risk, especially in people with chronic hepatitis B or C. Note: This is a screening tool only and does not replace imaging or professional medical evaluation. Results should be interpreted by a healthcare specialist.




